CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Announces Framework Agreement Regarding Fourth License – Zhejiang Province Enters New Province to Further Execute Geographic Expansion HONG KONG, China, September 15, 2010 - China Cord Blood Corporation Under the “One license per region policy” in China, only one cord blood bank license is granted in each province or municipality. The exclusive Zhejiang cord blood bank] [Framework Agreement on the Establishment of Zhejiang Provincial Cord Blood Hematopoietic Stem Cells Bank between Zhejiang Provincial Blood Center and Beijing Cord Blood Hematopoietic Stem Cells Bank Beijing Jiachenhong Biological Technologies Co., Ltd. September 2010 The Agreement has been hereby executed by and between the parties on 15, September 2010 (hereinafter referred to as “date of execution”) in Hangzhou, Zhejiang] [China Cord Blood Corporation Announces Mandate for Share Repurchase Program HONG KONG, China, September 15, 2010 - China Cord Blood Corporation Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation, stated, “Our board of directors approved this share Audio Webcast http://investor.chinacordbloodcorp.com/playerlink.zhtml?c=206671&s=wm&e=3368686 The Company will hold a teleconference at 9:30 p.m. ET on Wednesday, September 15, 2010 to give]

By | 2016-02-29T16:34:46+00:00 September 15th, 2010|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Announces Framework Agreement Regarding

[China Cord Blood Corporation Announces Framework Agreement Regarding Fourth License – Zhejiang Province Enters New Province to Further Execute Geographic Expansion HONG KONG, China, September 15, 2010 - China Cord Blood Corporation Under the “One license per region policy” in China, only one cord blood bank license is granted in each province or municipality. The exclusive Zhejiang cord blood bank] [Framework Agreement on the Establishment of Zhejiang Provincial Cord Blood Hematopoietic Stem Cells Bank between Zhejiang Provincial Blood Center and Beijing Cord Blood Hematopoietic Stem Cells Bank Beijing Jiachenhong Biological Technologies Co., Ltd. September 2010 The Agreement has been hereby executed by and between the parties on 15, September 2010 (hereinafter referred to as “date of execution”) in Hangzhou, Zhejiang] [China Cord Blood Corporation Announces Mandate for Share Repurchase Program HONG KONG, China, September 15, 2010 - China Cord Blood Corporation Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation, stated, “Our board of directors approved this share Audio Webcast http://investor.chinacordbloodcorp.com/playerlink.zhtml?c=206671&s=wm&e=3368686 The Company will hold a teleconference at 9:30 p.m. ET on Wednesday, September 15, 2010 to give]

By | 2016-02-29T16:35:37+00:00 September 15th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: (Original Filing)

[Chinard Bloodrporation Announces Frameworkreement Regarding Fourth License Zhejiang Province Enters New Province to Further Execute Geographic Expansion HONG KONG, China, September 15, 2010 - Chinard Bloodrporation Under the One license per region policy in China, only onerd blood bank license is granted in each province or municipality.The exclusive Zhejiangrd blood bank license represents the seventh] [Frameworkreement on the Establishment of Zhejiang Provincialrd Blood Hematopoietic Stem Cells Bank between Zhejiang Provincial Blood Center and Beijingrd Blood Hematopoietic Stem Cells Bank Beijing Jiachenhong Biological Technologies September 2010 Thereement has been hereby executed by and between the parties on 15, September 2010 (hereinafter referred tote of execution) in Hangzhou, Zhejiang Province, China.] [Chinard Bloodrporation Announces Mandate for Share Repurchase Program HONG KONG, China, September 15, 2010 - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporation, stated, Our board of directors approved this share Audio Webcast http://investor.chinacordbloodcorp.com/playerlink.zhtml?c=206671&s=wm&e=3368686 Thempany will hold a teleconference at 9:30 p.m. ET on Wednesday, September 15, 2010 to give a brief]

By | 2016-02-04T18:41:12+00:00 September 15th, 2010|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] 6-K: Chinard Bloodrporation Announces Frameworkreement Regarding Fourth License Zhejiang

[Chinard Bloodrporation Announces Frameworkreement Regarding Fourth License Zhejiang Province Enters New Province to Further Execute Geographic Expansion HONG KONG, China, September 15, 2010 - Chinard Bloodrporation Under the One license per region policy in China, only onerd blood bank license is granted in each province or municipality.The exclusive Zhejiangrd blood bank license represents the seventh] [Frameworkreement on the Establishment of Zhejiang Provincialrd Blood Hematopoietic Stem Cells Bank between Zhejiang Provincial Blood Center and Beijingrd Blood Hematopoietic Stem Cells Bank Beijing Jiachenhong Biological Technologies September 2010 Thereement has been hereby executed by and between the parties on 15, September 2010 (hereinafter referred tote of execution) in Hangzhou, Zhejiang Province, China.] [Chinard Bloodrporation Announces Mandate for Share Repurchase Program HONG KONG, China, September 15, 2010 - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporation, stated, Our board of directors approved this share Audio Webcast http://investor.chinacordbloodcorp.com/playerlink.zhtml?c=206671&s=wm&e=3368686 Thempany will hold a teleconference at 9:30 p.m. ET on Wednesday, September 15, 2010 to give a brief]

By | 2016-02-04T18:41:43+00:00 September 15th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC TO-C: (Original Filing)

[SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) CHINA CORD BLOOD CORPORATION (Name of Subject Company (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities) KYG211071181 ) Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. (Name, Address and Telephone Number of Person] [HONG KONG, China, September 13, 2010 - China Cord Blood Corporation Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation commented, “The proposed exchange offer will streamline and simplify our shareholding structure as well as corporate structure.” About China Cord Blood Corporation http://www.chinacordbloodcorp.com China Cord Blood Corporation is the first and largest cord blood banking operator in China]

By | 2016-02-29T16:37:57+00:00 September 13th, 2010|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC TO-C: SCHEDULE TO (Rule 14d-100) Tender Offer Statement under

[SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) CHINA CORD BLOOD CORPORATION (Name of Subject Company (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities) KYG211071181 ) Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. (Name, Address and Telephone Number of Person] [HONG KONG, China, September 13, 2010 - China Cord Blood Corporation Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation commented, “The proposed exchange offer will streamline and simplify our shareholding structure as well as corporate structure.” About China Cord Blood Corporation http://www.chinacordbloodcorp.com China Cord Blood Corporation is the first and largest cord blood banking operator in China]

By | 2016-02-29T16:39:27+00:00 September 13th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[HONG KONG, China, September 13, 2010 - China Cord Blood Corporation Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation commented, “The proposed exchange offer will streamline and simplify our shareholding structure as well as corporate structure.” About China Cord Blood Corporation http://www.chinacordbloodcorp.com China Cord Blood Corporation is the first and largest cord blood banking operator in China]

By | 2016-02-29T16:40:17+00:00 September 13th, 2010|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: HONG KONG, China, September 13, 2010 – China

[HONG KONG, China, September 13, 2010 - China Cord Blood Corporation Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation commented, “The proposed exchange offer will streamline and simplify our shareholding structure as well as corporate structure.” About China Cord Blood Corporation http://www.chinacordbloodcorp.com China Cord Blood Corporation is the first and largest cord blood banking operator in China]

By | 2016-02-29T16:42:02+00:00 September 13th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] SC TO-C: (Original Filing)

[SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section14(d)(1) or 13(e)(1) CHINARD BLOODRPORATION (Name of Subjectmpany (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities)G211071181 )bert Chen +852 3605 8180bert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong KongR.] [HONG KONG, China, September 13, 2010 - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporationmmented, The proposed exchange offer will streamline and simplify our shareholding structure wellrporate structure.out Chinard Bloodrporation http://www.chinacordbloodcorp.com Chinard Bloodrporation is the first and largestrd blood banking operator in China in terms of geographicalverage and is the onlyrd blood]

By | 2016-02-04T18:43:08+00:00 September 13th, 2010|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] SC TO-C: SCHEDULE TO (Rule 14d-100) Tender Offer Statement under

[SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section14(d)(1) or 13(e)(1) CHINARD BLOODRPORATION (Name of Subjectmpany (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities)G211071181 )bert Chen +852 3605 8180bert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong KongR.] [HONG KONG, China, September 13, 2010 - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporationmmented, The proposed exchange offer will streamline and simplify our shareholding structure wellrporate structure.out Chinard Bloodrporation http://www.chinacordbloodcorp.com Chinard Bloodrporation is the first and largestrd blood banking operator in China in terms of geographicalverage and is the onlyrd blood]

By | 2016-02-04T18:43:37+00:00 September 13th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar